De Novo JAK2 V617 F Positive AML: The Picture is Getting Clearer

被引:0
|
作者
Ghosh, Kanjaksha [1 ]
Ghosh, Kinjalka [2 ]
机构
[1] Surat Raktadan Kendra & Res Ctr, Haematol & Transfus Med, Surat, India
[2] Tata Canc Ctr, Clin Biochem, Ernest Borges Rd, Mumbai, Maharashtra, India
关键词
ACUTE MYELOID-LEUKEMIA;
D O I
10.1007/s12288-018-1041-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:360 / 361
页数:2
相关论文
共 50 条
  • [1] Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation
    Hidalgo-Lopez, Juliana E.
    Kanagal-Shamanna, Rashmi
    Medeiros, L. Jeffrey
    Estrov, Zeev
    Yin, C. Cameron
    Verstovsek, Srdan
    Konoplev, Sergej
    Jorgensen, Jeffrey L.
    Mohammad, M. Mohammad
    Miranda, Roberto N.
    Zhao, Chong
    Lee, John
    Zuo, Zhuang
    Bueso-Ramos, Carlos E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (06): : 790 - 796
  • [2] Clinical characteristics of a patient with de novo acute promyelocytic leukemia with JAK2 v617f mutation
    Jiang, Yi-zhi
    Wei, Zhong-ling
    Wang, Na-na
    Huang, Chen
    Huang, Jun
    Yan, Jia-wei
    Wang, Ran
    Yu, Zheng-zhi
    Huang, Dong-ping
    HEMATOLOGY, 2022, 27 (01) : 1290 - 1293
  • [3] Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation
    Ohanian, Maro
    Bueso-Ramos, Carlos
    Ok, Chi Young
    Lin, Pei
    Patel, Keyur
    Alattar, Mona Lisa
    Khoury, Joseph D.
    Rozovski, Uri
    Estrov, Zeev
    Huh, Yang O.
    Cortes, Jorge
    Abruzzo, Lynne V.
    CANCER GENETICS, 2015, 208 (11) : 571 - 574
  • [4] FLT3 internal tandem duplication and JAK2 V617F mutations in de novo acute myelogenous leukemia: relation with induction chemotherapy and overall survival
    Assem, Magda M.
    Noshy, Magda M.
    Elsayed, Ghada M.
    Nassar, Hanan R.
    Thabet, Gamal
    Sherif, Ghada M.
    Ahmad, Aida K.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (04): : 1053 - 1060
  • [5] Screening of V617F mutation in JAK2 gene with acute myeloid leukemia in the Saudi population
    Farasani, Abdullah
    ACTA BIOCHIMICA POLONICA, 2022, 69 (01) : 211 - 214
  • [6] JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms
    Oh, Stephen T.
    Gotlib, Jason
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (03) : 323 - 337
  • [7] JAK2 V617F mutation, multiple hematologic and non-hematologic processes: An association?
    Liu K.G.
    Verma A.
    Derman O.
    Kornblum N.
    Janakiram M.
    Braunschweig I.
    Battini R.
    Biomarker Research, 4 (1)
  • [8] Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele
    Anelli, Luisa
    Orsini, Paola
    Zagaria, Antonella
    Minervini, Angela
    Coccaro, Nicoletta
    Parciante, Elisa
    Minervini, Crescenzio Francesco
    Cumbo, Cosimo
    Tota, Giuseppina
    Impera, Luciana
    Conserva, Maria Rosa
    Redavid, Immacolata
    Tarantini, Francesco
    Ricco, Alessandra
    Attolico, Immacolata
    Specchia, Giorgina
    Albano, Francesco
    LEUKEMIA, 2021, 35 (02) : 619 - 622
  • [9] Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
    Machado-Neto, Joao Agostinho
    Fenerich, Bruna Alves
    Scopim-Ribeiro, Renata
    Eide, Christopher A.
    Coelho-Silva, Juan Luiz
    Porto Dechandt, Carlos Roberto
    Fernandes, Jaqueline Cristina
    Nunes Rodrigues Alves, Ana Paula
    Scheucher, Priscila Santos
    Simoes, Belinda Pinto
    Alberici, Luciane Carla
    de Figueiredo Pontes, Lorena Lobo
    Tognon, Cristina E.
    Druker, Brian J.
    Rego, Eduardo Magalhaes
    Traina, Fabiola
    CELL DEATH & DISEASE, 2018, 9
  • [10] Infrequent V617F mutation of the JAK2 gene in myeloid leukemia and its absence in lymphoid malignancies in Japan
    Mori, Naoki
    Yoshinaga, Kentaro
    Tada, Makiko
    Wang, Yanhua
    Shiseki, Masayuki
    Motoji, Toshiko
    GENETICS AND MOLECULAR BIOLOGY, 2008, 31 (02) : 427 - 430